These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20194250)

  • 1. Analysis of the effect of serum interleukin-6 (IL-6) and soluble IL-6 receptor levels on survival of patients with colorectal cancer.
    Yeh KY; Li YY; Hsieh LL; Lu CH; Chou WC; Liaw CC; Tang RP; Liao SK
    Jpn J Clin Oncol; 2010 Jun; 40(6):580-7. PubMed ID: 20194250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer.
    Andrews B; Shariat SF; Kim JH; Wheeler TM; Slawin KM; Lerner SP
    J Urol; 2002 Mar; 167(3):1475-81. PubMed ID: 11832773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
    Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
    Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer.
    Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
    Hepatogastroenterology; 2002; 49(43):160-4. PubMed ID: 11941943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative interleukin-6 production by mononuclear blood cells predicts survival after radical surgery for colorectal carcinoma.
    Clinchy B; Fransson A; Druvefors B; Hellsten A; Håkansson A; Gustafsson B; Sjödahl R; Håkansson L
    Cancer; 2007 May; 109(9):1742-9. PubMed ID: 17345614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum interleukin-6 levels reflect the disease status of colorectal cancer.
    Chung YC; Chang YF
    J Surg Oncol; 2003 Aug; 83(4):222-6. PubMed ID: 12884234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble intercellular adhesion molecule-1 as a prognostic marker for stage II colorectal cancer patients.
    Toiyama Y; Miki C; Inoue Y; Okugawa Y; Koike Y; Yokoe T; Tanaka K; Kusunoki M
    Ann Surg Oncol; 2008 Jun; 15(6):1617-24. PubMed ID: 18368454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies.
    De Vita F; Orditura M; Galizia G; Romano C; Infusino S; Auriemma A; Lieto E; Catalano G
    Cancer; 1999 Nov; 86(10):1936-43. PubMed ID: 10570416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum soluble interleukin-2 receptor (IL-2R) and immunohistochemical staining of IL-2R/Tac antigen in colorectal cancer.
    Sakata H; Murakami S; Hirayama R
    Int J Clin Oncol; 2002 Oct; 7(5):312-7. PubMed ID: 12402066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma.
    Zhang GJ; Adachi I
    Anticancer Res; 1999; 19(2B):1427-32. PubMed ID: 10365118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer.
    Barber MD; Fearon KC; Ross JA
    Clin Sci (Lond); 1999 Jan; 96(1):83-7. PubMed ID: 9857110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of inflammatory cytokines in the progression of colorectal cancer.
    Chung YC; Chang YF
    Hepatogastroenterology; 2003; 50(54):1910-3. PubMed ID: 14696431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of tissue expression of interleukin-6 in colorectal carcinoma.
    Chung YC; Chaen YL; Hsu CP
    Anticancer Res; 2006; 26(5B):3905-11. PubMed ID: 17094421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predictive of survival in patients with node-positive colorectal cancer in Taiwan.
    Wang WS; Chen PM; Chiou TJ; Liu JH; Fan FS; Lin TC; Jiang JK; Yang SH; Yen CC; Wang HS; Lin JK
    Hepatogastroenterology; 2000; 47(36):1590-4. PubMed ID: 11149009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum interleukin-12 levels in patients with gastric cancer.
    Murakami S; Okubo K; Tsuji Y; Sakata H; Hamada S; Hirayama R
    Surg Today; 2004; 34(12):1014-9. PubMed ID: 15580384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between circulating interleukin-6 and carcinoembryonic antigen in patients with colorectal cancer.
    Nakagoe T; Tsuji T; Sawai T; Tanaka K; Hidaka S; Shibasaki S; Nanashima A; Yamaguchi H; Yasutake T; Sugawara K; Inokuchi N; Kamihira S
    Anticancer Res; 2003; 23(4):3561-4. PubMed ID: 12926107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer.
    Szaflarska A; Szczepanik A; Siedlar M; Czupryna A; Sierzega M; Popiela T; Zembala M
    Anticancer Res; 2009 Dec; 29(12):5005-12. PubMed ID: 20044609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble interleukin-2 receptor serum level as a predictor of locoregional control and survival for patients with head and neck carcinoma: results of a multivariate prospective study.
    Tartour E; Deneux L; Mosseri V; Jaulerry C; Brunin F; Point D; Validire P; Dubray B; Fridman WH; Rodriguez J
    Cancer; 1997 Apr; 79(7):1401-8. PubMed ID: 9083163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of lymphovascular invasion in sporadic colorectal cancer.
    Lim SB; Yu CS; Jang SJ; Kim TW; Kim JH; Kim JC
    Dis Colon Rectum; 2010 Apr; 53(4):377-84. PubMed ID: 20305435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.